FDA Extends Comment Period On Generic Drugs Rule
The U.S. Food and Drug Administration said Wednesday it will give drugmakers and others an additional two months to comment on its closely watched proposal to allow generic-drug manufacturers to independently...To view the full article, register now.
Already a subscriber? Click here to view full article